期刊文献+

口服中药联合人工肝治疗重型肝炎的疗效观察 被引量:2

Treating Severe Type Hepatitis with Oral Traditional Chinese Medicine Concomitant with Artificial Liver:Observation of Curative Efficacy
下载PDF
导出
摘要 目的:观察口服中药联合人工肝治疗重型肝炎的疗效。方法:176例重型肝炎患者随机分为治疗组与对照组。对照组给予内科基础治疗和人工肝治疗,治疗组在对照组治疗基础上加服中药,疗程为2wk。结果:治疗组与对照组的治愈率分别为45·5%、20·5%(P<0·01);存活率分别为65·9%、40·9%(P<0·05)。结论:口服中药联合人工肝治疗重型肝炎疗效较佳。 OBJECTIVE: To observe the clinical efficacy of oral traditional Chinese medicine concomitant with artificial liver in the treatment of severe type hepatitls.METHODS: A total of 176 patients were randomly divided into the treatment group and control group: the control group was treated with conventional internal medicine therapy together with artificial liver, while the treatment group was treated with additional traditional Chinese medicine besides the therapy for the control group.And the course of treatment was 2 weeks.RESULTS:The cure rates for the treatment group and the control group were 45.5 % and 20.5 %, respectively( P 〈 0.01) ; the survival rates were 65.9 % and 40,9%, respectively ( P 〈 0.05). CONCLUSION : The therapy of oral traditional Chinese medicine concomitant with artificial liver is of better curative efficacy in the treatment of severe type hepatitis.
出处 《中国药房》 CAS CSCD 北大核心 2006年第4期286-288,共3页 China Pharmacy
关键词 中药 人工肝治疗 重型肝炎 疗效 Traditional Chinese medicine Artificial liver treatment Severe hepatitis Curative efficacy
  • 相关文献

参考文献5

二级参考文献26

共引文献14018

同被引文献19

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2Polson J, Lee WM.American; AASLD position paper:the management of acute liver failure[J]. Hepatology, 2005, 41(5):1 179.
  • 3Lee WM.Etiologies of acute liver failure[J]. Semin Liver Dis,2008,28(2) : 142.
  • 4Rolando N, Wade J, Davalos M, et al. The systemic inflammatory response syndrome in acute liver failure[J]. Hepatology, 2000,32(4 Pt 1):734.
  • 5Pappas PG, Andes D, Schuster M, et al.Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study[J].Am J Transplant, 2006,6 (2) : 386.
  • 6Nola I, Kostovic K, Oremovic L, et al. Candida infections today: How big is the problem? [J]. Acta Dermatovenerol Croat,2003,11(3) : 171.
  • 7Meersseman W, Lagrou K, Maertens J, et al.Invasive aspergillosis in the intensive care unit[J].Clin Infect Dis,2007,45(2):205.
  • 8Pazos C, Ponton J, Del Palacio A. Contribution of 1, 3-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan[J].J Clin Microbiol, 2005,43 ( 1 ) : 299.
  • 9Rex JH, Sobel JD.Prophylactic antifungal therapy in the intensive care unit[J]. Clin Infect Dis, 2 001,32 (8) : 1 191.
  • 10Casadevall A, Pirofski LA.Adjunctive immune therapy for fungal infections[J]. Clin Infect Dis, 2001,33 (7):1 048.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部